BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17383147)

  • 21. Painful subacute thyroiditis (de Quervain's thyroiditis).
    Peter SA
    J Natl Med Assoc; 1992 Oct; 84(10):877-9. PubMed ID: 1404465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dengue Fever Presenting Atypically with Viral Conjunctivitis and Subacute Thyroiditis.
    Sheraz F; Tahir H; Saqi J; Daruwalla V
    J Coll Physicians Surg Pak; 2016 Jun; 26(6 Suppl):S33-4. PubMed ID: 27376214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the therapeutic effects of prednisolone and nonsteroidal anti-inflammatory drugs in patients with subacute thyroiditis.
    Sato J; Uchida T; Komiya K; Goto H; Takeno K; Suzuki R; Honda A; Himuro M; Watada H
    Endocrine; 2017 Jan; 55(1):209-214. PubMed ID: 27688010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic analysis of subacute (de Quervain's) thyroiditis.
    Goto H; Uno H; Tamai H; Kuma K; Hayashi Y; Matsubayashi S; Sasazuki T
    Tissue Antigens; 1985 Aug; 26(2):110-3. PubMed ID: 3877350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. De Quervain subacute thyroiditis.
    Mundy-Baird G; Kyriacou A; Syed AA
    CMAJ; 2021 Jul; 193(26):E1007. PubMed ID: 34226265
    [No Abstract]   [Full Text] [Related]  

  • 26. Graves' disease occurring after subacute thyroiditis: report of a case and review of the literature.
    Bartalena L; Bogazzi F; Pecori F; Martino E
    Thyroid; 1996 Aug; 6(4):345-8. PubMed ID: 8875758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two-Years Prospective Follow-Up Study of Subacute Thyroiditis.
    Zhao N; Wang S; Cui XJ; Huang MS; Wang SW; Li YG; Zhao L; Wan WN; Li YS; Shan ZY; Teng WP
    Front Endocrinol (Lausanne); 2020; 11():47. PubMed ID: 32184756
    [No Abstract]   [Full Text] [Related]  

  • 28. Characteristics of patients with subacute thyroiditis.
    Kjellerup CR; Thomsen MJ; Torp NMU; Karmisholt J; Andersen SL
    Dan Med J; 2023 Oct; 70(11):. PubMed ID: 37897374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Risk of Recurrence of Subacute Thyroiditis Is HLA-Dependent.
    Stasiak M; Tymoniuk B; Stasiak B; Lewiński A
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30832406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Evaluation of the Results of the Steroid and Non-steroidal Anti-inflammatory Drug Treatments in Subacute Thyroiditis in relation to Persistent Hypothyroidism and Recurrence.
    Sencar ME; Calapkulu M; Sakiz D; Hepsen S; Kus A; Akhanli P; Unsal IO; Kizilgul M; Ucan B; Ozbek M; Cakal E
    Sci Rep; 2019 Nov; 9(1):16899. PubMed ID: 31729433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmsted County, Minnesota, study.
    Fatourechi V; Aniszewski JP; Fatourechi GZ; Atkinson EJ; Jacobsen SJ
    J Clin Endocrinol Metab; 2003 May; 88(5):2100-5. PubMed ID: 12727961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subacute thyroiditis during early pregnancy: a case report and literature review.
    Bai CF; Shen GH; Yang Y; Yang K; R Hayden M; Zhou YY; Geng XQ
    BMC Pregnancy Childbirth; 2022 Jan; 22(1):19. PubMed ID: 34996368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extent of hypoechogenic area in the thyroid is related with thyroid dysfunction after subacute thyroiditis.
    Nishihara E; Amino N; Ohye H; Ota H; Ito M; Kubota S; Fukata S; Miyauchi A
    J Endocrinol Invest; 2009 Jan; 32(1):33-6. PubMed ID: 19337012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA-B35 influences the apoptosis rate in human peripheral blood mononucleated cells and HLA-transfected cells.
    Salazar G; Colombo G; Lenna S; Antonioli R; Beretta L; Santaniello A; Scorza R
    Hum Immunol; 2007 Mar; 68(3):181-91. PubMed ID: 17349873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Studies on the pathogenesis of subacute thyroiditis].
    Kobayashi N; Tamai H; Nagai K; Matsubayashi S; Matsuzuka F; Kuma K; Goto H; Uno H; Sasazuki T; Nagataki S
    Nihon Naibunpi Gakkai Zasshi; 1985 Jul; 61(7):737-43. PubMed ID: 2998895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Initial treatment with 15 mg of prednisolone daily is sufficient for most patients with subacute thyroiditis in Japan.
    Kubota S; Nishihara E; Kudo T; Ito M; Amino N; Miyauchi A
    Thyroid; 2013 Mar; 23(3):269-72. PubMed ID: 23227861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of recurrence in 36 subacute thyroiditis patients managed with prednisolone.
    Mizukoshi T; Noguchi S; Murakami T; Futata T; Yamashita H
    Intern Med; 2001 Apr; 40(4):292-5. PubMed ID: 11334386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Subacute thyroiditis in practice of a clinician].
    Kobel'nitskaia LA; Petrova EB; Platonova NM; Troshina EA; Il'in AB
    Voen Med Zh; 2006 Jun; 327(6):68-74. PubMed ID: 16898296
    [No Abstract]   [Full Text] [Related]  

  • 39. HLA and self-limiting, unclassified rheumatism. A role for HLA-B35?
    Dubost JJ; Demarquilly F; Soubrier M; Coussediere C; Ristori JM; Sauvezie BJ
    J Rheumatol; 1999 Nov; 26(11):2400-3. PubMed ID: 10555900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA-B35, a common genetic trait, in a familial case of Henoch-Schoenlein purpura and Berger's disease.
    Pellegrin MC; Matarazzo L; Neri E; Pennesi M; Crovella S
    Genet Mol Res; 2014 Apr; 13(2):2669-73. PubMed ID: 24782055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.